Serotonin Syndrome: SSRIs, SNRIs, Triptans, and Current Clinical Practice
Author:
- 6 January 2012
- journal article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 52 (2) , 195-197
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin SyndromeHeadache: The Journal of Head and Face Pain, 2012
- The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin‐Norepinephrine Reuptake Inhibitors: American Headache Society Position PaperHeadache: The Journal of Head and Face Pain, 2010
- Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A ReviewHeadache: The Journal of Head and Face Pain, 2010
- Serotonin Syndrome Associated with Triptan MonotherapyNew England Journal of Medicine, 2008
- The Serotonin Syndrome, Triptans, and the Potential for Drug–Drug InteractionsHeadache: The Journal of Head and Face Pain, 2007
- The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicityQJM: An International Journal of Medicine, 2003
- Coprescription of Triptans With Potentially Interacting Medications: A Cohort Study Involving 240 268 PatientsHeadache: The Journal of Head and Face Pain, 2003
- The serotonin syndromeAmerican Journal of Psychiatry, 1991